Medindia

X

Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting

Tuesday, May 17, 2011 General News J E 4
Advertisement
Results Support Avanafil Safety and Efficacy Profile through 52 Weeks of Treatment

CONTACT:

VIVUS, Inc.

Investor Relations:

The Trout Group

Timothy E. Morris

Brian Korb

Chief Financial Officer

646-378-2923

650-934-5200

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Tea Party Attacks Gingrich, Romney, R.I.N.O.'s
S
Food Allergies Common among Children and Linked to...